Levosemotiadil

TargetMol
Product Code: TAR-T25701
Supplier: TargetMol
CodeSizePrice
TAR-T25701-5mg5mg£1,251.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25701-50mg50mg£2,464.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25701-100mg100mg£3,283.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Levosemotiadil is an antiarrhythmic compound that has vasodilator properties.
CAS:
116476-16-5
Formula:
C29H32N2O6S
Molecular Weight:
536.64
Purity:
0.98
SMILES:
COc1ccc(OCCCN(C)CCOc2ccc3OCOc3c2)c(c1)[C@@H]1Sc2ccccc2N(C)C1=O

References

1. Adamson PB, Vanoli E, Shibano T, Foreman RD, Schwartz PJ. Combined sodium and calcium channel blockade in prevention of lethal arrhythmias. J Cardiovasc Pharmacol. 2003 May;41(5):665-70. PubMed PMID: 12717095. 2. Ueda K, Yamaoka K, Rodriguez ME, Shibukawa A, Nakagawa T. Enantioselective local disposition of semotiadil (R-enantiomer) and levosemotiadil (S-enantiomer) in perfused rat liver. Drug Metab Dispos. 1997 Mar;25(3):281-6. PubMed PMID: 9172944. 3. Rodriguez Rosas ME, Shibukawa A, Yoshikawa Y, Kuroda Y, Nakagawa T. Binding study of semotiadil and levosemotiadil with alpha(1)-acid glycoprotein using high-performance frontal analysis. Anal Biochem. 1999 Oct 1;274(1):27-33. PubMed PMID: 10527493. 4. Rodriguez Rosas ME, Shibukawa A, Ueda K, Nakagawa T. Enantioselective protein binding of semotiadil and levosemotiadil determined by high-performance frontal analysis. J Pharm Biomed Anal. 1997 Jun;15(9-10):1595-601. PubMed PMID: 9226594.